Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 7.


Swann, Olivia V, Pollock, Louisa, Holden, Karl A, Munro, Alasdair PS, Bennett, Aisleen, Williams, Thomas C, Turtle, Lance, Fairfield, Cameron J, Drake, Thomas M, Faust, Saul N
et al (show 16 more authors) (2022) Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves. PEDIATRIC RESEARCH, 93 (1). pp. 207-216.


Swann, Olivia ORCID: 0000-0001-7386-2849, Pollock, Louisa ORCID: 0000-0002-4240-325X, Holden, Karl, Munro, Alasdair PS ORCID: 0000-0002-4317-0742, Bennett, Aisleen, Williams, Thomas ORCID: 0000-0002-3866-1344, Turtle, Lance ORCID: 0000-0002-0778-1693, Fairfield, Cameron ORCID: 0000-0001-7635-1868, Drake, Thomas, Faust, Saul ORCID: 0000-0003-3410-7642
et al (show 15 more authors) (2021) Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study. [Preprint]


Zhu, Yanshan, Almeida, Flavia Jacqueline, Baillie, J Kenneth, Bowen, Asha C, Britton, Philip N, Brizuela, Martin Eduardo, Buonsenso, Danilo, Burgner, David, Chew, Keng Yih, Chokephaibulkit, Kulkanya
et al (show 39 more authors) (2023) International Pediatric COVID-19 Severity Over the Course of the Pandemic. JAMA PEDIATRICS, 177 (10). pp. 1073-1084.


Liu, Xinxue, Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 48 more authors) (2022) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. JOURNAL OF INFECTION, 84 (6). pp. 795-813.


Liu, Xinxue, Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 48 more authors) (2023) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial (vol 84, pg 795, 2022). JOURNAL OF INFECTION, 86 (5). pp. 540-541.


Munro, Alasdair PS, Janani, Leila, Cornelius, Victoria, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna, Dodd, Kate
et al (show 44 more authors) (2021) Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. LANCET, 398 (10318). pp. 2258-2276.


Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Cornelius, Victoria, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 45 more authors) (2022) Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. LANCET INFECTIOUS DISEASES, 22 (8). pp. 1131-1141.

This list was generated on Mon Apr 22 05:37:38 2024 BST.